{
    "root": "3016064e-3329-e2e8-e063-6294a90aae09",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Mupirocin",
    "value": "20250311",
    "ingredients": [
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "MUPIROCIN",
            "code": "D0GX863OA5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7025"
        }
    ],
    "indications": {
        "text": "mupirocin ointment usp , 2 % indicated topical treatment impetigo due susceptible isolates staphylococcus aureus ( s. aureus ) streptococcus pyogenes ( s. pyogenes ) .",
        "doid_entities": [
            {
                "text": "impetigo (DOID:8504)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8504"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "topical . apply small amount mupirocin ointment , cotton swab gauze pad , affected area 3 times daily 10 days . cover treated area gauze dressing desired . re-evaluate patients showing response within 3 5 days . mupirocin ointment intranasal , ophthalmic , mucosal [ ( 5.2 , 5.6 ) ] . apply mupirocin ointment concurrently lotions , creams , ointments [ pharmacology ( 12.3 ) ] .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gram mupirocin ointment contains 20 mg mupirocin water-miscible ointment base . mupirocin ointment usp , 2 % supplied follows : ndc 50268-568-15 ( 50 individual one gram tubes ) dispensed unit dose packaging . institutional .",
    "adverseReactions": "mupirocin ointment contraindicated patients known hypersensitivity mupirocin excipients mupirocin ointment .",
    "indications_original": "Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of \n       \n \n  Staphylococcus aureus (S. aureus) and \n       \n \n  Streptococcus pyogenes (S. pyogenes).",
    "contraindications_original": "For Topical Use Only.\n                     Apply a small amount of mupirocin ointment, with a cotton swab or gauze pad, to the affected area 3 times daily for up to 10 days.\n                     Cover the treated area with gauze dressing if desired.\n                     Re-evaluate patients not showing a clinical response within 3 to 5 days.\n                     Mupirocin ointment is not for intranasal, ophthalmic, or other mucosal use \n        \n  \n   [see \n         \n   \n    Warnings and Precautions (5.2, \n         \n   \n    5.6)]\n        \n  \n   .\n       \n \n  \n                     Do not apply mupirocin ointment concurrently with any other lotions, creams, or ointments \n        \n  \n   [see \n         \n   \n    Clinical Pharmacology (12.3)]\n        \n  \n   .",
    "warningsAndPrecautions_original": "Each gram of mupirocin ointment contains 20 mg mupirocin in a water-miscible ointment base.\n                  Mupirocin Ointment USP, 2% is supplied as follows:\n                  NDC 50268-568-15 (50 individual one gram tubes)\n                  \n                  Dispensed in Unit Dose Packaging. For Institutional Use Only.",
    "adverseReactions_original": "Mupirocin ointment is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of mupirocin ointment.",
    "drug": [
        {
            "name": "Mupirocin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7025"
        }
    ]
}